Theragnostics (AgeTech UK) Medical
Targeted cancer medicine through radiatherapy, radiolabelled PARP inhibitors. Theragnostics was incorporated in the UK in 2015 with the aim of providing a portfolio of products to transform patient care in oncology through targeted molecular radiotherapy and molecular imaging diagnostic products.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership